Jun 2026 (Q1 FY27) — Aug 5, 2026
e.l.f. Beauty Q1 FY27 — Strong Sales Growth and Raised Outlook Driven by Portfolio Strength
Read the full calle.l.f. Beauty earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 479 | +35.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 21.4 | +7.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 66.6 | +99.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
1Y: $136.92 on 17 Oct 2025 → $113.48. High $136.92 (17 Oct 2025), low $49.57 (5 Jun 2026).
Overview
Call summaries
e.l.f. Beauty Q1 FY27 — Strong Sales Growth and Raised Outlook Driven by Portfolio Strength
Read the full calle.l.f. Beauty Q4 FY26 — Strong Portfolio Growth Despite Core Brand Moderation
Read the full callEvery analysed call
Financials
Net profit, year on year: +100% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 301 | 355 | 333 | 354 | 344 | 490 | 449 | 479 |
| Operating profit | 28 | 35 | 44 | 49 | 8 | 68 | -50 | 102 |
| Operating margin | 9.3% | 9.9% | 13.3% | 13.8% | 2.2% | 13.8% | −11.2% | 21.4% |
| Profit before tax | 28 | 26 | 44 | 51 | -4 | 54 | -61 | 94 |
| Tax rate | 31.9% | 34.3% | 35.8% | 34.8% | 175.1% | 26.9% | 18.4% | 29.4% |
| Net profit | 19 | 17 | 28 | 33 | 3 | 39 | -49 | 67 |
| EPS ($ per share) | 0.34 | 0.31 | 0.50 | 0.59 | 0.05 | 0.66 | -0.84 | 1.13 |
| Line item | Dec 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | -512 | -512 | -505 | -484 | -422 | -294 | -182 | -156 |
| Total liabilities | 207 | 211 | 218 | 182 | 185 | 487 | 487 | 1,264 |
| Fixed assets | 22 | 17 | 14 | 11 | 8 | 14 | 29 | 41 |
| Total assets | 436 | 453 | 487 | 495 | 596 | 1,129 | 1,248 | 2,394 |
| Line item | Dec 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 56 | 44 | 29 | 20 | 102 | 71 | 134 | 213 |
| Cash from investing | -9 | -35 | -6 | -5 | -2 | -285 | -19 | -605 |
| Cash from financing | -6 | -17 | -11 | -29 | -23 | 201 | -74 | 534 |
| Net cash flow | 41 | -8 | 12 | -14 | 77 | -13 | 41 | 141 |
| Capital expenditure | -9 | -9 | -6 | -5 | -2 | -9 | -19 | -22 |
| Free cash flow | 47 | 35 | 23 | 15 | 100 | 62 | 115 | 190 |
| Segment | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | Q1 FY2027 | YoY growth latest quarter |
|---|---|---|---|---|---|---|
| Reportable | 100% | 100% | 100% | 100% | 100% | +35.5% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Q1 FY2027 · share of revenue
As ELF cuts its regions in its filings; they can nest, so they need not add to 100%.
95 filings between Nov 11, 2025 and Oct 12, 2026.
Purchases
$464.8K
1 purchase by 1 insider
Sales
$30.53M
39 sales by 7 insiders
33% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 23 gifts, 6 other filings.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| AMIN TARANG | — | $12.12M | Oct 1, 2026 |
| Franks Joshua Allen | — | $4.16M | Oct 12, 2026 |
| Hartnett Jennifer Catherine | — | $4.11M | Jul 1, 2026 |
| FIELDS MANDY J | — | $3.85M | Sep 8, 2026 |
| MARCHISOTTO KORY | — | $3.25M | Aug 4, 2026 |
| Milsten Scott | — | $2.24M | Jun 9, 2026 |
| Levitan Lauren Cooks | — | $800.2K | Aug 18, 2026 |
| FARRELL MATTHEW | $464.8K | — | Feb 20, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Franks Joshua Allen SVP, Operations | Sale 10b5-1 plan | 8,366 | $920.3K |
| Oct 1, 2026 | AMIN TARANG Chief Executive Officer | Sale 10b5-1 plan | 2,026 | $212.7K |
| Oct 1, 2026 | AMIN TARANG Chief Executive Officer | Option exercise 10b5-1 plan | 71,000 | $1.91M |
| Oct 1, 2026 | AMIN TARANG Chief Executive Officer | Sale 10b5-1 plan | 23,072 | $2.37M |
| Oct 1, 2026 | AMIN TARANG Chief Executive Officer | Sale 10b5-1 plan | 21,902 | $2.27M |
| Sep 8, 2026 | FIELDS MANDY J See Remarks | Sale 10b5-1 plan | 2,850 | $301.1K |
| Sep 8, 2026 | FIELDS MANDY J See Remarks | Sale 10b5-1 plan | 600 | $64.0K |
| Sep 8, 2026 | FIELDS MANDY J See Remarks | Sale 10b5-1 plan | 7,965 | $827.0K |
| Sep 8, 2026 | FIELDS MANDY J See Remarks | Sale 10b5-1 plan | 4,650 | $487.0K |
| Sep 8, 2026 | Franks Joshua Allen SVP, Operations | Sale | 200 | $22.0K |
| Sep 4, 2026 | Franks Joshua Allen SVP, Operations | Gift | 3,300 | $0 |
| Sep 1, 2026 | AMIN TARANG Chief Executive Officer | Other | 20,326 | — |
| Sep 1, 2026 | AMIN TARANG Chief Executive Officer | Other | 20,326 | — |
| Sep 1, 2026 | AMIN TARANG Chief Executive Officer | Gift | 20,836 | $0 |
| Sep 1, 2026 | AMIN TARANG Chief Executive Officer | Other | 20,326 | — |
| Sep 1, 2026 | AMIN TARANG Chief Executive Officer | Other | 20,326 | — |
| Sep 1, 2026 | AMIN TARANG Chief Executive Officer | Other | 20,836 | — |
| Sep 1, 2026 | AMIN TARANG Chief Executive Officer | Other | 20,836 | — |
| Sep 1, 2026 | AMIN TARANG Chief Executive Officer | Gift | 20,836 | $0 |
| Sep 1, 2026 | Franks Joshua Allen SVP, Operations | Sale 10b5-1 plan | 5,512 | $606.3K |
| Aug 20, 2026 | Keith Lori Director | Award | 1,985 | $0 |
| Aug 20, 2026 | Levitan Lauren Cooks Director | Award | 1,421 | $0 |
| Aug 20, 2026 | Mitchell Kenneth Jr Director | Award | 1,980 | $0 |
| Aug 20, 2026 | Tait Gayle Director | Award | 1,421 | $0 |
| Aug 20, 2026 | Daniele Tiffany F. Director | Award | 1,421 | $0 |
| Aug 20, 2026 | Watson Maureen C. Director | Award | 1,939 | $0 |
| Aug 20, 2026 | FARRELL MATTHEW Director | Award | 1,421 | $0 |
| Aug 20, 2026 | Bergh Charles V Director | Award | 1,878 | $0 |
| Aug 20, 2026 | Ferreras Maria Director | Award | 1,909 | $0 |
| Aug 19, 2026 | Franks Joshua Allen SVP, Operations | Sale 10b5-1 plan | 5,718 | $571.8K |
| Aug 18, 2026 | Levitan Lauren Cooks Director | Sale | 1,034 | $96.3K |
| Aug 4, 2026 | MARCHISOTTO KORY See Remarks | Sale | 12,173 | $1.07M |
| Jul 1, 2026 | AMIN TARANG Chief Executive Officer | Option exercise 10b5-1 plan | 71,000 | $1.91M |
| Jul 1, 2026 | Hartnett Jennifer Catherine Chief Commercial Officer | Sale 10b5-1 plan | 25,357 | $2.03M |
| Jun 10, 2026 | AMIN TARANG Chief Executive Officer | Gift | 30,758 | $0 |
| Jun 10, 2026 | AMIN TARANG Chief Executive Officer | Gift | 30,758 | $0 |
| Jun 10, 2026 | AMIN TARANG Chief Executive Officer | Gift | 18,097 | $0 |
| Jun 10, 2026 | AMIN TARANG Chief Executive Officer | Gift | 18,097 | $0 |
| Jun 9, 2026 | AMIN TARANG Chief Executive Officer | Sale | 7,000 | $360.7K |
| Jun 9, 2026 | Hartnett Jennifer Catherine Chief Commercial Officer | Sale | 4,352 | $224.3K |
| Jun 9, 2026 | Milsten Scott Insider | Sale | 4,162 | $214.5K |
| Jun 9, 2026 | Franks Joshua Allen SVP, Operations | Sale | 3,505 | $180.6K |
| Jun 9, 2026 | FIELDS MANDY J See Remarks | Sale | 4,327 | $223.0K |
| Jun 9, 2026 | MARCHISOTTO KORY See Remarks | Sale | 4,352 | $224.3K |
| Jun 4, 2026 | AMIN TARANG Chief Executive Officer | Sale | 15,829 | $822.2K |
| Jun 4, 2026 | MARCHISOTTO KORY See Remarks | Sale | 8,512 | $442.1K |
| Jun 4, 2026 | Milsten Scott Insider | Sale | 8,512 | $442.1K |
| Jun 4, 2026 | Hartnett Jennifer Catherine Chief Commercial Officer | Sale | 10,318 | $535.9K |
| Jun 4, 2026 | Franks Joshua Allen SVP, Operations | Sale | 6,854 | $356.0K |
| Jun 4, 2026 | FIELDS MANDY J See Remarks | Sale | 8,464 | $439.6K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow e.l.f. Beauty, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading